SCHEMBL6422585

SCHEMBL6422585

COCCOc1ccc2[nH]c(C(N)=O)cc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFD P00746 1/20 0.56
PDGFRB P09619 6/20 0.54
PDGFRA P16234 6/20 0.54
XDH P47989 1/20 0.53
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 4/20 0.53
MAPT P10636 2/20 0.53
FLT3 P36888 4/20 0.52
L3MBTL1 Q9Y468 2/20 0.50
HPGD P15428 2/20 0.50
FGFR1 P11362 1/20 0.50
FGFR2 P21802 1/20 0.50
FGFR3 P22607 1/20 0.50
NPC1 O15118 1/20 0.50
LMNA P02545 1/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.50
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4816031 0.88 KDM4E (0.64) PDGFRBPDGFRAXDHKDM4EALDH1A1
SCHEMBL2659656 0.87 XDH (0.57) PDGFRBPDGFRAXDHKDM4EALDH1A1
SCHEMBL6422580 0.86 PDGFRB (0.54) PDGFRBPDGFRAXDHKDM4EALDH1A1
SCHEMBL17775019 0.84 KDM4E (0.60) PDGFRBPDGFRAXDHKDM4EALDH1A1
SCHEMBL17775020 0.84 KDM4E (0.60) PDGFRBPDGFRAXDHKDM4EALDH1A1
SCHEMBL17775017 0.84 KDM4E (0.60) PDGFRBPDGFRAXDHKDM4EALDH1A1
SCHEMBL17775018 0.84 KDM4E (0.60) PDGFRBPDGFRAXDHKDM4EALDH1A1
SCHEMBL15222304 0.84 PDGFRB (0.51) PDGFRBPDGFRAXDHKDM4EALDH1A1
SCHEMBL17775023 0.84 KDM4E (0.60) PDGFRBPDGFRAXDHKDM4EALDH1A1
SCHEMBL17775016 0.84 KDM4E (0.60) PDGFRBPDGFRAXDHKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005118584-A2 SAFRAMYCIN ANALOGS AS THERAPEUTIC AGENTS IN THE TREATMENT OF CANCER AXYS PHARMACEUTICALS, INC. (US) 2005-12-15 WO disclosed